BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26123235)

  • 41. A Systematic Review and Meta-Analysis of the Prevalence of Methamphetamine Abuse in Iranian High School Students.
    Sayyah M; Shirbandi K; Javanmardi F; Rahim F
    J Med Life; 2018; 11(4):262-268. PubMed ID: 30894880
    [No Abstract]   [Full Text] [Related]  

  • 42. Women-only drug treatment services and needs in Iran: the first review of current literature.
    Alam-mehrjerdi Z; Daneshmand R; Samiei M; Samadi R; Abdollahi M; Dolan K
    Daru; 2016 Feb; 24():3. PubMed ID: 26893096
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence and Risk Factors of Emergency Department Presentations with Methamphetamine Intoxication or Dependence: A Systematic Review and Meta-analysis.
    Sibanda NC; Kornhaber R; Hunt GE; Morley K; Cleary M
    Issues Ment Health Nurs; 2019 Jul; 40(7):567-578. PubMed ID: 31025889
    [No Abstract]   [Full Text] [Related]  

  • 44. A qualitative exploration of the factors associated with initiation to methamphetamine use in Iran.
    Shahbazi Sighaldeh S; Zarghami F; Shahryari A; Mohammadinia A; Ebrahimi M; Jorjani T; Hamrah MS; Charkazi A
    BMC Public Health; 2020 Nov; 20(1):1773. PubMed ID: 33228618
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amphetamine-type stimulant use among men who have sex with men (MSM) in Vietnam: Results from a socio-ecological, community-based study.
    Vu NT; Holt M; Phan HT; Le HT; La LT; Tran GM; Doan TT; Nguyen TN; de Wit J
    Drug Alcohol Depend; 2016 Jan; 158():110-7. PubMed ID: 26656138
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlates of shared methamphetamine injection among methamphetamine-injecting treatment seekers: the first report from Iran.
    Mehrjerdi ZA; Abarashi Z; Noroozi A; Arshad L; Zarghami M
    Int J STD AIDS; 2014 May; 25(6):420-7. PubMed ID: 24287028
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Increasing prevalence of amphetamine--and methamphetamine-induced psychosis].
    Härtel-Petri R; Rodler R; Schmeisser U; Steinmann J; Wolfersdorf M
    Psychiatr Prax; 2005 Jan; 32(1):13-7. PubMed ID: 15633070
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The association of controlling pseudoephedrine availability on methamphetamine-related emergency department visits.
    Hendrickson RG; Cloutier RL; Fu R
    Acad Emerg Med; 2010 Nov; 17(11):1216-22. PubMed ID: 21175520
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Crystal methamphetamine use associated with non-fatal overdose among a cohort of injection drug users in Vancouver.
    Fairbairn N; Wood E; Stoltz JA; Li K; Montaner J; Kerr T
    Public Health; 2008 Jan; 122(1):70-8. PubMed ID: 17645904
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methamphetamine use among Australian workers and its implications for prevention.
    Roche AM; Pidd K; Bywood P; Freeman T
    Drug Alcohol Rev; 2008 May; 27(3):334-41. PubMed ID: 18368616
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical course and outcomes of methamphetamine-dependent adults with psychosis.
    Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson R;
    J Subst Abuse Treat; 2008 Dec; 35(4):445-50. PubMed ID: 18294802
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of methamphetamine abuse: research findings and clinical directions.
    Cretzmeyer M; Sarrazin MV; Huber DL; Block RI; Hall JA
    J Subst Abuse Treat; 2003 Apr; 24(3):267-77. PubMed ID: 12810148
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Associations between methamphetamine use and HIV among men who have sex with men: a model for guiding public policy.
    Shoptaw S; Reback CJ
    J Urban Health; 2006 Nov; 83(6):1151-7. PubMed ID: 17111217
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study.
    McKetin R; Lubman DI; Baker AL; Dawe S; Ali RL
    JAMA Psychiatry; 2013 Mar; 70(3):319-24. PubMed ID: 23303471
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacotherapeutic agents in the treatment of methamphetamine dependence.
    Morley KC; Cornish JL; Faingold A; Wood K; Haber PS
    Expert Opin Investig Drugs; 2017 May; 26(5):563-578. PubMed ID: 28351169
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Review of Methamphetamine Dependence and Withdrawal Treatment: A Focus on Anxiety Outcomes.
    Hellem TL
    J Subst Abuse Treat; 2016 Dec; 71():16-22. PubMed ID: 27776672
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dual epidemics of syphilis and methamphetamine use among drug users in Shandong Province of China.
    Liao M; Kang D; Tao X; Li J; Qian Y; Wang G; Jiang B; Bi Z; Jia Y
    AIDS Care; 2013; 25(10):1236-44. PubMed ID: 23394142
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The scourge of methamphetamine.
    Thomas SP
    Issues Ment Health Nurs; 2009 Aug; 30(8):473. PubMed ID: 19591019
    [No Abstract]   [Full Text] [Related]  

  • 59. Methamphetamine use, dependence and treatment access in rural and regional North Coast of New South Wales, Australia.
    Wallace C; Galloway T; McKetin R; Kelly E; Leary J
    Drug Alcohol Rev; 2009 Nov; 28(6):592-9. PubMed ID: 19930011
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Demographic and mental history-related data predicted occurrence of psychosis in metamphetamine users.
    Farnia V; Shakeri J; Tatari F; Juibari TA; Bajoghli H; Golshani S; Hookari S; Holsboer-Trachsler E; Brand S
    Psychiatry Res; 2016 Jun; 240():431-434. PubMed ID: 27172885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.